Complications of Blood Transfusions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Transfusion Service Introduction Blood/Blood Products Requests and Turnaround Time Expectations
Transfusion Service Introduction All blood products and blood components are supplied to UnityPoint Health-Meriter Hospital by the American Red Cross Blood Services. Pathology consultation is available regarding blood and/or components and dosages. ABO and Rho(D)—specific type is used whenever possible for leuko-poor packed cell transfusions. ABO-compatible blood is used for all plasma and platelet components whenever possible. For any orders involving HLA-matched components, the patient must have been HLA typed (sent to the American Red Cross) a minimum of 48 hours prior to intended infusion of the component. HLA typing is only required once. Blood components that are thawed, pooled, washed, volume-reduced, or deglycerolized for a patient will be charged to the patient even if not transfused. The charge is done because these components may not be suitable for another patient. Examples include: Autologous or directed donations Pooled cryoprecipitate 4-hour expiration Thawed fresh frozen plasma 24-hour expiration Thawed cryoprecipitate 6-hour expiration Deglycerolized red cells 24-hour expiration Washed red cells 24-hour expiration All blood components must be completely infused within 4 hours of release from UnityPoint Health-Meriter Laboratories Blood Bank, or be infused within the expiration time. Refer to UnityPoint Health -Meriter’s Blood and Blood Products Transfusion Policy #123 for additional information located on MyMeriter. Blood/Blood Products Requests and Turnaround Time Expectations Requests from UnityPoint Health-Meriter Hospital are entered in the hospital computer system and print in the UnityPoint Health- Meriter Laboratories Blood Bank. For the comfort of the patient, it is important to coordinate collection for other tests with Blood Bank specimens. -
Complication Prevention for Patients with Diabetes a Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients
Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients The Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients results from the contributions and hard work of many people. Its development was led by Dr Hai-Rim Shin, Coordinator, and Dr Warrick Junsuk Kim, Medical Officer, of the Noncommunicable Diseases and Health Promotion unit at the WHO Regional Office for the Western Pacific (WHO/WPRO/NCD) in Manila, Philippines. WHO graciously acknowledges the intellectual contributions of Dr Jung-jin Cho, Co-director, Community-based Primary Care Project Committee and Professor, Department of Family Medicine, Hallym University Sacred Heart Dongtan Hospital, Republic of Korea; Dr Hyejin Lee, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Family Medicine, Seoul National University, Republic of Korea); Ms Saki Narita, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Japan); and Mr Byung Ki Kwon, Technical Officer, WHO/WPRO/NCD (currently Director, Division of Health Promotion, Ministry of Health and Welfare, Republic of Korea). Many thanks to Dr Albert Domingo, Dr Sonia McCarthy, Ms Marie Clem Carlos, Dr Katrin Engelhardt, Mr Kelvin Khow Chuan Heng and Dr Roberto Andres Ruiz from the WHO Regional Office for the Western Pacific and Dr Ma. Charina Benedicto, Physician-in-Charge, Bagong Barangay Health Center & Lying-in Clinic, Pandacan, Manila, Philippines for reviewing the draft publication. Financial support for this publication was received from the Korea Centers for Disease Control and Prevention, Republic of Korea. -
Risk Factors and Complications in Type 2 Diabetes Outpatients
RISKORIGINAL FACTORS AND COMPLICATIONS ARTICLE IN TYPE 2 DIABETES OUTPATIENTS Risk factors and complications in type 2 diabetes outpatients ELLEN FERNANDES FLávIO SILVA1, CRISTIANE MARIA MENDES FERREIRA2*, LUCINEIA DE PINHO3 1Medical Student, Faculdades Unidas do Norte de Minas (Funorte), Montes Claros, MG, Brazil 2Endocrinologist, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil 3PhD in Health Sciences, Unimontes and Funorte, Montes Claros, MG, Brazil SUMMARY Objective: Our study investigated type 2 diabetes mellitus (T2DM) outpatients attending a university hospital in Montes Claros, MG, to estimate the prevalence of risk factors and their association with diabetes complications. Method: This was a quantitative, documental, retrospective and analytical study. Medical records of 95 outpatients with T2DM treated in this hospital from 2011 to 2015 were analyzed. Data were collected according to a structured questionnaire surveying sociodemographic, anthropometric and biochemical data and clinical and lifestyle aspects. Regression analysis was used to evaluate the association between risk factor variables and complications. Results: With a mean age of 54 years, the study population showed irregular blood glucose control, despite the use of hypoglycemic medication, and did not Study conducted at Universidade have a healthy lifestyle. The main complication reported was high blood pressure Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil (HBP), occurring in 70.9% of patients. The prevalence of complications was positively associated with patients receiving insulin treatment (p=0.042) and Article received: 11/13/2016 Accepted for publication: 12/19/2016 multidisciplinary monitoring (p=0.050). Conclusion: The associations identified reflect the condition of patients that *Correspondence: Address: Av. Dr. -
Patient's Guide to Blood Transfusions
Health Information For Patients and the Community A Patient’s Guide to Blood Transfusions Your doctor may order a blood transfusion as part of your therapy. This brochure will focus on frequently asked questions about blood products, transfusions, and the risks and benefits of the blood transfusion. PLEASE NOTE: This information is not intended to replace the medical advice of your doctor or health care provider and is intended for educational purposes only. Individual circumstances will affect your individual risks and benefits. Please discuss any questions or concerns with your doctor. What is a blood transfusion? A blood transfusion is donated blood given to patients with abnormal blood levels. The patient may have abnormal blood levels due to blood loss from trauma or surgery, or as a result of certain medical problems. The transfusion is done with one or more of the following parts of blood: red blood cells, platelets, plasma, or cryoprecipitate. What are the potential benefits of a blood transfusion? If your body does not have enough of one of the components of blood, you may develop serious life-threatening complications. • Red blood cells carry oxygen through your body to your heart and brain. Adequate oxygen is very important to maintain life. • Platelets and cryoprecipitate help to prevent or control bleeding. • Plasma replaces blood volume and also may help to prevent or control bleeding. How safe are blood transfusions? Blood donors are asked many questions about their health, behavior, and travel history in order to ensure that the blood supply is as safe as it can be. Only people who pass the survey are allowed to donate. -
Patient Information Leaflet – Plasma Exchange Procedure
Therapeutic Apheresis Services Patient Information Leaflet – Plasma Exchange Procedure Introduction Antibodies, which normally help to protect you from infection, can begin to attack your own This leaflet has been written to give patients healthy cells, or an over production of proteins can information about plasma exchange (sometimes cause your blood to become thicker and slow down called plasmapheresis). If you would like any more the blood flow throughout your body. A plasma information or have any questions, please ask the exchange can help improve your symptoms, doctors and nurses involved in your treatment at although this may not happen immediately. the NHS Blood and Transplant (NHSBT) Therapeutic Apheresis Services Unit. Although plasma exchange may help with symptoms, it will not normally cure your condition When you have considered the information given as it does not switch off the production of the in this leaflet, and after we have discussed the harmful antibodies or proteins. It is likely that procedure and its possible risks with you, we will this procedure will form only one part of your ask you to sign a consent form to indicate that you treatment. are happy for the procedure to go ahead. Before any further procedures we will again check that you are happy to proceed. How do we perform Plasma Exchange? What is a plasma exchange? Plasma exchange is performed using a machine Blood is made up of red cells, white cells and called a Blood Cell Separator which can separate platelets which are carried around in fluid called blood into its various parts. The machine separates plasma. -
Your Guide to Living Well with Heart Disease
YOUR GUIDE TO Living Well Wi t h H e a rt Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute NIH Publication No. 06–5270 November 2005 Written by: Marian Sandmaier U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute C o n t e n t s Introduction . 1 Heart Disease: A Wakeup Call . 2 What Is Heart Disease? . 4 Getting Tested for Heart Disease . 7 Controlling Your Risk Factors . 10 You and Your Doctor: A Healthy Partnership . 12 Major Risk Factors . 13 Smoking . 13 High Blood Pressure . 14 High Blood Cholesterol . 18 Overweight and Obesity . 23 Physical Inactivity. 26 Diabetes . 27 What Else Affects Heart Disease? . 31 Stress . 31 Alcohol . 31 Sleep Apnea. 32 Menopausal Hormone Therapy . 33 C-Reactive Protein . 33 Treatments for Heart Disease . 34 Medications . 34 Managing Angina . 38 Procedures. 41 Coronary Angioplasty, or “Balloon” Angioplasty. 42 Plaque Removal . 42 Stent Placement . 42 Coronary Bypass Surgery . 44 Getting Help for a Heart Attack. 46 Know the Warning Signs. 46 Get Help Quickly . 46 Plan Ahead. 49 Recovering Well: Life After a Heart Attack or Heart Procedure. 51 Your First Weeks at Home. 52 Cardiac Rehabilitation . 55 Getting Started . 55 How To Choose a Cardiac Rehab Program . 56 What You’ll Do in a Cardiac Rehab Program. 56 Getting the Most Out of Cardiac Rehab . 57 Getting Your Life Back . 59 Coping With Your Feelings . 60 Caring for Your Heart . 63 To Learn More . 64 1 I n t r o d u c t i o n Chances are, you’re reading this book because you or someone close to you has heart disease. -
What Is Dvt? Deep Vein Thrombosis (DVT) Occurs When an Abnormal Blood Clot Forms in a Large Vein
What is DVt? Deep vein thrombosis (DVT) occurs when an abnormal blood clot forms in a large vein. These clots usually develop in the lower leg, thigh, or pelvis, but can also occur in other large veins in the body. If you develop DVT and it is diagnosed correctly and quickly, it can be treated. However, many people do not know if they are at risk, don’t know the symptoms, and delay seeing a healthcare professional if they do have symptoms. CAn DVt hAppen to me? Anyone may be at risk for DVT but the more risk factors you have, the greater your chances are of developing DVT. Knowing your risk factors can help you prevent DVt: n Hospitalization for a medical illness n Recent major surgery or injury n Personal history of a clotting disorder or previous DVT n Increasing age this is serious n Cancer and cancer treatments n Pregnancy and the first 6 weeks after delivery n Hormone replacement therapy or birth control products n Family history of DVT n Extended bed rest n Obesity n Smoking n Prolonged sitting when traveling (longer than 6 to 8 hours) DVt symptoms AnD signs: the following are the most common and usually occur in the affected limb: n Recent swelling of the limb n Unexplained pain or tenderness n Skin that may be warm to the touch n Redness of the skin Since the symptoms of DVT can be similar to other conditions, like a pulled muscle, this often leads to a delay in diagnosis. Some people with DVT may have no symptoms at all. -
37267-A-Rare-Complication-Of-Myocardial-Infarction-Ventricular-Septal-Defect.Pdf
Open Access Case Report DOI: 10.7759/cureus.9725 A Rare Complication of Myocardial Infarction: Ventricular Septal Defect Sherif Elkattawy 1 , Ramez Alyacoub 1 , Muhammad Atif Masood Noori 1 , Afrah Talpur 1 , Karim Khimani 2 1. Internal Medicine, Rutgers New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA 2. Internal Medicine, Rutger New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA Corresponding author: Karim Khimani, [email protected] Abstract Ventricular septal defect (VSD) is a rare but lethal complication of myocardial infarction. We present a case of a 65-year-old male who presented with a history of progressive shortness of breath associated with productive cough. Physical examination was significant for crepitation in both lower lung fields and bilateral lower extremity edema. Chest X-ray revealed bilateral reticular opacities with small bilateral pleural effusions. Polymerase chain reaction (PCR) for COVID was positive. Echo showed a left ventricular ejection fraction (LVEF) of 30-35%, ischemic cardiomyopathy, and muscular ventricular septal defects with left to right shunting and severely elevated pulmonary artery systolic pressure. Overtime during the hospital course, he developed respiratory and fulminant hepatic failure. Our patient had VSD due to an undiagnosed old myocardial infarction (MI). Initially heart failure was compensated and treated with medical management. Later on, he developed respiratory complications related to COVID-19 infection as well as hepatic failure in addition to a cardiomyopathy which made him a poor surgical candidate leading to death. Categories: Cardiac/Thoracic/Vascular Surgery, Cardiology, Internal Medicine Keywords: ventricular septal defect (vsd), complication of mi, interventricular septum Introduction A ventricular septal defect (VSD) is an abnormal communication between the left and right ventricle through a defect in the septal wall of the heart. -
Terminology Resource File
Terminology Resource File Version 2 July 2012 1 Terminology Resource File This resource file has been compiled and designed by the Northern Assistant Transfusion Practitioner group which was formed in 2008 and who later identified the need for such a file. This resource file is aimed at Assistant Transfusion Practitioners to help them understand the medical terminology and its relevance which they may encounter in the patient’s medical and nursing notes. The resource file will not include all medical complaints or illnesses but will incorporate those which will need to be considered and appreciated if a blood component was to be administered. The authors have taken great care to ensure that the information contained in this document is accurate and up to date. Authors: Jackie Cawthray Carron Fogg Julia Llewellyn Gillian McAnaney Lorna Panter Marsha Whittam Edited by: Denise Watson Document administrator: Janice Robertson ACKNOWLEDGMENTS We would like to acknowledge the following people for providing their valuable feedback on this first edition: Tony Davies Transfusion Liaison Practitioner Rose Gill Transfusion Practitioner Marie Green Transfusion Practitioner Tina Ivel Transfusion Practitioner Terry Perry Transfusion Specialist Janet Ryan Transfusion Practitioner Dr. Hazel Tinegate Consultant Haematologist Reviewed July 2012 Next review due July 2013 Version 2 July 2012 2 Contents Page no. Abbreviation list 6 Abdominal Aortic Aneurysm (AAA) 7 Acidosis 7 Activated Partial Thromboplastin Time (APTT) 7 Acquired Immune Deficiency Syndrome -
HPN Complication Chart
HPN Complication Chart Users are strongly advised to review this chart with their MD, noting any differences in protocols/procedures, prior to taking 214 Hun Memorial, MC 28 any actions recommended by this chart. The chart is intended as a helpful reference, and should not replace the advice of Albany Medical Center your MD. Users should read the entire chart, at least briefly, comparing symptoms listed in each section with those actually experienced by the consumer, before taking any action. Albany, NY 12208 (800) 776-OLEY/(518) 262-5079 Fax: (518) 262-5528 www.oley.org [email protected] METABOLIC (Catheter/Pump Complications on Back) Infection Symptoms: Temperature one degree or more above baseline/normal temperature; chills, especially occurring with infusion; sweating; lethargy; body aches; urine spot checks may show glucose levels greater than 1/2%. A. systemic Cause: Poor aseptic technique during connection/disconnection procedures; contaminated tubing or heparin or saline flushes; infection: contaminated IV solution; exposure to illness outside body (flu, cold, chicken pox, etc.) or inside body (urinary tract infection, dental abscess/caries, fistulae, ileostomy/colostomy/gastrostomy sites, etc.); routine dental work without prophylactic antibiotic coverage. Immediate Action: Call MD immediately. If MD unavailable, go to local emergency room. Prevention: Use proper aseptic technique at all times, including meticulous handwashing. Inspect all solutions beforehand for clouding/particulate matter. If possible, avoid individuals with known illnesses or possible exposure to communicable diseases. Schedule routine dental checkups; inform dentist of indwelling central venous access (catheter) and follow protocol for prophylactic antibiotic coverage for dental work as prescribed by primary MD (call Oley for suggested protocol if needed). -
Laboratory Best Transfusion Practice for Neonates, Infants and Children
Laboratory Best Transfusion Practice for Neonates, Infants and Children This summary guidance should be used in conjunction with the appropriate 20161 and 20122 BSH Guidelines and laboratory SOPs Compatibility testing Neonates and infants < 4 months Obtain neonatal and maternal transfusion history (including any fetal transfusions) for all admissions. Obtain a maternal sample for initial testing where possible, in addition to the patient sample. Red cell selection: no maternal antibodies present Select appropriate group and correct neonatal specification red cells. Group O D-negative red cells may be issued electronically without serological crossmatch. If the laboratory does not universally select group O D-negative red cells for this age group, blood group selection should either be controlled by the LIMS or an IAT crossmatch should be performed using maternal or neonatal plasma to serologically confirm ABO compatibility with both mother and neonate. Red cell selection: where there is maternal antibody Select appropriate group red cells, compatible with maternal alloantibody/ies. An IAT crossmatch should be performed using the maternal plasma. If it is not possible to obtain a maternal sample it is acceptable to crossmatch antigen-negative units against the infant’s plasma. Where paedipacks are being issued from one donor unit it is only necessary to crossmatch the first split pack. Subsequent split packs from this multi-satellite unit can be automatically issued without further crossmatch until the unit expires or the infant is older than 4 months. If packs from a different donor are required, an IAT crossmatch should be performed. Infants and children ≥ 4 months For infants and children from 4 months of age, pre-transfusion testing and compatibility procedures should be performed as recommended for adults. -
Cardiovascular Disease As One of the Main Complication of Uncontrolled Diabetes
SHORT COMMUNICATION Diabetes Management Cardiovascular disease as one of the main complication of uncontrolled diabetes Amira Ragab El Barky* & Tarek Mostafa Mohamed ABSTRACT Diabetes mellitus is a metabolic disorder, which is characterized by chronic hyperglycemia and disturbances of the metabolism of carbohydrate, fat and protein that resulted due to defects in insulin secretion, action or both of them. People with diabetes are prone to increased risk of many diseases, such as cardiac, peripheral arterial and cerebrovascular disease. There are many people with diabetes that refuse to take their medication such as insulin or synthetic drugs to reduce and control their raised blood glucose level. They depend on, when they eat much sweetness food, take their medication. So, this commentary discusses some of the complications of uncontrolled diabetes mellitus and their relation with cardiovascular disease. Introduction productivity of leukocyte adhesion molecules and pro-inflammatory mediators [6]. This Patients suffering from diabetes are prone to augmented vascular inflammatory reaction increased risk factors for Cardiovascular Disease might result from over expression of the receptor (CVD), blindness, end-stage of renal disease, for advanced glycation end products. The and legs fingers or leg amputations [1]. People receptors for advanced glycation end products suffering from diabetes had a two to eight-fold promote matrix metalloproteinase activity that more risk of developing heart disease as well as can destabilize plaques [7]. an increased risk factor of mortality by up to 3 times [2,3]. The Changes which occur in the vascular function give the poorer outcomes in diabetes mellitus. The Diabetic people are more potential to have increment of the levels of endothelin-1 enhances coronary artery disease, which is multi vessel, vasoconstriction, prompt vascular smooth muscle and to have episodes of silent myocardial hypertrophy, and activates the renin-angiotensin.